Evidence map›Paper›PMID 36534943›Full record

ArticleSleep2023

Short sleep duration is associated with lower cerebrospinal fluid amyloid beta 42 levels in midlife: a preliminary report.

Madeline Gibson, Jessica Nicolazzo, Marina Cavuoto, Ella Rowsthorn, Lachlan Cribb, Lisa Bransby, Rachel Buckley, Nawaf Yassi, Stephanie Yiallourou, Amy Brodtmann and 6 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Sleep, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Short Sleep Duration and Hypertension: A Double Hit for the Brain.Journal of the American Heart Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Madeline GibsonThe Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.ORCID 0000-0002-8102-2775
Jessica NicolazzoThe Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.ORCID 0000-0001-5044-0766
Marina CavuotoThe Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.
Ella RowsthornThe Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.
Lachlan CribbThe Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.
Lisa BransbyThe Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.
Rachel BuckleyMelbourne School of Psychological Sciences, University of Melbourne, Parkville, Victoria, Australia.ORCID 0000-0002-5356-5537
Nawaf YassiDepartment of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.
Stephanie YiallourouThe Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.
Amy BrodtmannDepartment of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.
Dennis VelakoulisNeuropsychiatry at The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Dhamidhu EratneNeuropsychiatry at The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Garun S HamiltonMonash Lung, Sleep, Allergy and Immunology, Monash Health, Clayton, Victoria, Australia.
Matthew T NaughtonDepartment of Respiratory Medicine, Alfred Health and Central Clinical School, Melbourne, Victoria, Australia.
Yen Ying LimThe Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.
Matthew P PaseThe Turner Institute for Brain and Mental Health, Monash University, Clayton, Victoria, Australia.

Funding

Contributions of sleep to preclinical and clinical Alzheimer's diseaseR01AG062531 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HIMALI, JAYANDRA JUNG, PASE, MATTHEW · 2020 to 2023
$3.1M
Elucidating the mechanisms underlying sex differences in cognitive decline due to preclinical Alzheimer's diseaseK99AG061238 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI BUCKLEY, RACHEL FRANCES · 2019 to 2020
$273k
NIA NIH HHS K99 AG061238NIA NIH HHS R01 AG062531
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesHumansPeptide FragmentsSleep DurationAmyloid beta-Peptidesamyloid beta-protein (1-42)Peptide FragmentsAlzheimer’s diseaseamyloidbiomarkerscerebrospinal fluidsleepsleep duration

Identifiers

PMID36534943
PMCPMC10091085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.